Pulmonary resection for extensively drug resistant tuberculosis in Kwazulu-Natal, South Africa
- PMID: 22633500
- PMCID: PMC3567439
- DOI: 10.1016/j.athoracsur.2012.03.072
Pulmonary resection for extensively drug resistant tuberculosis in Kwazulu-Natal, South Africa
Abstract
Background: Extensively drug resistant tuberculosis (XDR-TB) has been reported in 58 countries around the world and has emerged as a major public health challenge. Our objective was to determine the impact of pulmonary resection on XDR-TB treatment outcomes in a resource-constrained setting.
Methods: We conducted a retrospective case review of 11 patients with XDR-TB who were referred for pulmonary resection between January 2007 and June 2010 at a tertiary care referral hospital in South Africa. Two pneumonectomies and three upper lobectomies were performed. Occurrence of surgical complications and TB treatment outcome were assessed.
Results: No perioperative mortality or major morbidity was noted. All patients achieved sputum conversion, with 4 regarded as "cured." One patient defaulted on treatment, but subsequently returned and is regarded as a probable cure.
Conclusions: We describe pulmonary resection for XDR-TB management in Africa. Although the initial cohort of XDR-TB patients from Tugela Ferry demonstrated nearly complete mortality, our results demonstrate the potential of adjuvant surgical methods in XDR-TB treatment. With appropriate chemotherapy and timely adjuvant surgery, patients with XDR-TB localized to lobe or lung may achieve a "cure" with low morbidity and mortality. Consequently, this approach may be the most cost effective treatment for patients suitable for lung resection.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Invited commentary.Ann Thorac Surg. 2012 Aug;94(2):386. doi: 10.1016/j.athoracsur.2012.05.001. Ann Thorac Surg. 2012. PMID: 22818300 No abstract available.
References
-
- The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization; 2010. (Report no. WHO/HTM/TB/2010.3)
-
- Revised definition of extensively drug resistant tuberculosis. MMWR Morb Mortal Wkly Rep. 2006;55:301–5. - PubMed
-
- Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006 Nov 4;368(9547):1575–80. - PubMed
-
- Madariaga MG, Lalloo UG, Swindells S. Extensively drug-resistant tuberculosis. Am J Med. 2008 Oct;121(10):835–44. - PubMed
-
- Migliori GB, Besozzi G, Girardi E, et al. Clinical operational value of the extensively drug-resistant tuberculosis definition. Euro Respir J. 2007;30:623–626. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
